Amedysis ($AMED) comparison – From $1 to $300”… If you understand this, the CEO's Chris' vision that Nova Leap Health is an early Amedysis, whose share during the parable had grown from $1 to then over $300 are not too hard to catch.”
Listen from 14:40-16:50 here:
https://www.youtube.com/watch?v=HJRsvWoyhXA&t=1105s
https://twitter.com/BetulaKapital/status/1478760735610216449